dihexa fda approval status Big news for peptides! In July, the will meet to evaluate the most commonly used peptides for FDA authorized compounding Dihexa (PNB-0408) | c-Met/HGFR Activator

References Sung J et al

Wolverine Stack: A Scientific Analysis of BPC-157 and TB-500 Combination Research The Wolverine Stack refers to the combination of two peptides studied in preclinical research: BPC-157, a synthetic pentadecapeptide derived from human gastric juice that modulates the nitric oxide system and VEGFR2-mediated angiogenesis, and TB-500, a synthetic analog of thymosin beta-4 that regulates actin dynamics and cellular migration

All products are for in-vitro research use only

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide made of 15 amino acids, derived from a fragment of a protective protein found in human gastric juice

For patients with limited budgets, he typically recommends starting with BPC-157 alone (since it has the larger evidence base for most applications) and adding TB-500 only if the response to BPC-157 alone is insufficient

This is not an argument for or against peptides